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Solid tumours are supplied with lower oxygen levels than normal
tissues because of poorly developed vasculature and sporadic
occlusions of blood vessels. Severe hypoxia below 0.3% oxygen is
frequently registered in melanomas, breast, cervical, head and
neck cancers and is thought be the single most important cause of
clinical radioresistance (Dachs and Stratford, 1996; Dachs and
Tozer, 2000). The hypoxic tumour microenvironment is also
responsible for the selection of malignant clones that overexpress
hypoxia-inducible genes responsible for tumour angiogenesis.
Besides vascular endothelial growth factor, a direct mediator of
vascularization, the cytokine-inducible form of nitric oxide
synthase (iNOS) appears to respond to a hypoxia stress since its
activation is detected in many solid tumours (Thomsen et al, 1994,
1995; Ambs et al, 1998; Thomsen and Miles, 1998). This enzyme
utilizes L-arginine to produce the nitric oxide radical (NO) that
promotes tumour growth at low concentrations (Wink et al, 1998;
Dachs and Tozer, 2000). However, as we have recently demon-
strated in EMT-6 tumour cells, the induction of iNOS by cytokines
in aerobic conditions can trigger an NO production high enough to
reverse hypoxia-induced radioresistance (Janssens et al, 1998).
The question of how this mechanism is influenced by chronic
hypoxia is essential and may determine whether it can be exploited
as a novel hypoxia-selective target. 
The present study is a first step in this direction and explores the
possibility that chronic hypoxia may modulate hypoxic cell
radioresponse through up-regulation of iNOS. We asked whether
hypoxia alone may cause iNOS induction or whether cooperation
with cytokines is required to achieve full iNOS expression.
Secondly, we examined the activity of iNOS after chronic hypoxia
and evaluated NO-mediated hypoxic cell radiosensitization. 
MATERIALS AND METHODS 
Chemicals 
All reagents were obtained from Sigma Chemical Co (St. Louis,
MO, USA) unless otherwise stated. 
Cell culture 
Murine mammary adenocarcinoma EMT-6 cells were kindly
provided by Dr Edith Lord (University of Rochester, Cancer
Center, New York, USA). The cells (passages 15–40) were propa-
gated in RPMI 1640 medium (Gibco, Paisley, United Kingdom)
supplemented with 10% bovine calf serum (HyClone Laboratories
Inc Logan, Utah, USA) in plastic flasks (Greiner, Frickenhausen,
Germany). 
iNOS induction by cytokines 
EMT-6 monolayer cultures grown to early confluence were
exposed to IL-1b plus IFN-g for 16 h in normoxia or hypoxia. To
obtain chronic hypoxia, culture flasks were placed in sealed cham-
bers and subjected to repeated vacuum evacuation/injection of
nitrogen/CO2-balanced gas containing 0.03 or 1% oxygen. Further
processing of cells was done as described below. 
Western and Northern blot analysis 
After iNOS induction, the protein and mRNA levels of iNOS were
estimated by Western and Northern blotting as described previously
(Janssens et al, 1998). Briefly, lysates from 1 ´ 105 cells were
resolved in a 7.5% polyacrylamide-SDS gel, blots were stained with
the monoclonal antibody to iNOS (Affiniti Research Products,
Exeter, UK) and analysed by an immunoperoxidase-based ECL tech-
nique (Amersham). RNA samples (10 mg) were electrophoresced on
formaldehyde agarose gels, transferred to HyBond-N membranes
(Amersham) and probed with 32P-labelled 1.8-kb mouse iNOS
cDNA fragment (Alexis Corporation, Laufelfingen, Switzerland). 
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After iNOS induction, amperometric measurements of NO were
performed in cell suspensions (30 ´ 106 ml–1, 37˚C) in ambient
atmosphere. The NO signal was registered by an Iso-NOP200
microsensor (World Precision Instruments, Hertfordshire, UK) and
data were expressed in nA (Janssens et al, 1998). 
Determination of nitrite 
After iNOS induction, cultures were washed out from cytokines
and re-incubated during 24 h in normoxia to accumulate nitrite, an
oxidative product of NO. The nitrite level in the medium was
determined using the Griess reaction as described elsewhere
(Titheradge, 1998). 
Radiosensitivity 
After iNOS induction, the cells were harvested from cultures by
trypsinization and micropellets (0.5 ´ 106 cells) were produced in
conical tubes by centrifugation at 300 g for 5 min. Metabolic
oxygen depletion in micropellets was induced by incubation at
37˚C for 3 min prior to radiation. Using this procedure for various
mouse and human tumour cells, we have previously found oxygen
enhancement ratios in the range of 2.5–3.0 indicating radiobiolog-
ically relevant hypoxia (Verovski et al, 1996; Janssens et al, 1998,
1999). Micropellets were irradiated with a linear accelerator at a
rate of 2 Gy per min and survival after 4, 8, 12 and 16 Gy was
measured by a 8-day colony formation assay. Radiosensitization
was evaluated at the level of 0.1 surviving fraction. 
Statistics 
All assays were repeated at least 3 times. Data are expressed as
means (symbols, columns) with corresponding standard deviations
(SD, bars). 
RESULTS 
EMT-6 cultures were exposed to IFN-g plus IL-1b for 16 h in
varying oxygen concentrations and afterwards cells were analysed
for iNOS expression and production of nitrite, an oxidized
metabolite of NO. Normoxia (21% oxygen) was compared to 1%
and 0.03% oxygen, respectively modeling reduced oxygenation in
tumour tissue and radiobiologically relevant hypoxia. 
In aerobic cells, Western blots demonstrated activation of
iNOS expression at 3–10 units ml–1 cytokines while in the
absence of cytokines no iNOS protein was found (Figure 1). In
0.03 and 1%  oxygen, cytokines substantialy up-regulated iNOS
expression that became evident at 0.3–1 units ml–1. The hypoxic
up-regulation of iNOS by cytokines resulted in appearance of
active enzyme since the accumulation of nitrite in the medium at
0.3–1 units ml–1 was increased over the next 24 h (Figure 2). A
low but detectable level of iNOS protein and activity was found
in the samples exposed to hypoxia without cytokines. Northern
blot data were in agreement with the protein expression and
suggested a transcriptional up-regulation of iNOS induction in
hypoxia (Figure 1). There was some increase in iNOS up-regula-
tion in 0.03% compared with 1% oxygen but deep hypoxia
during 16 h caused cytotoxicity. Therefore, further experiments
were conducted in 1% oxygen. 
To measure NO output, concentrated cell suspensions were
prepared from EMT-6 cultures treated or not with cytokines, and
the NO signal was registered at 37˚C using a NO-specific
microsensor (Figure 3). At 1 unit ml–1, hypoxic but not aerobic
treatment resulted in a substantial NO signal in line with the blot
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Figure 1 Western and Northern blot analysis of iNOS protein and mRNA
expression in EMT-6 cells after a 16 h exposure to IFN-g and IL-1b in 21%
(A), 1% (B) or 0.03% (C) oxygen 
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Figure 2 Nitrite production in EMT-6 cells after a 16 h exposure to IFN-g
and IL-1b in 21% (n n) 1% ( ) or 0.03% (n) oxygen. The nitrite was
accumulated in the medium during a 24 h re-incubation period and
determined by the Griess reaction and Griess data (Figures 1 and 2). In absence of cytokines, only
a background level of NO production was observed for both
treatments. At cytokine concentrations higher than 1 units ml–1,
comparable iNOS activity was found in hypoxia and normoxia. 
We have already demonstrated iNOS-induced radiosensitization
in cell micropellets subjected to metabolic oxygen depletion, and
identified L-arginine-derived NO as a radiosensitizer (Janssens et
al, 1998). The same model was applied to verify the increased
radiosensitizing potency of cytokines under hypoxic versus
aerobic conditions. As shown in Figure 4A, the radiosensitivity of
EMT-6 cells exposed to 1 unit ml–1 cytokines in 21% oxygen was
unchanged. Strikingly, the same concentration of cytokines in 1%
oxygen induced a 1.8-fold radiosensitization (Figure 4B). A raised
concentration of cytokines (3 units ml–1) was active under both
hypoxic and aerobic conditions and caused comparable radiosensi-
tization (2.1 to 2.3-fold) approaching the radiosensitizing effect of
oxygen (2.5-fold). In the absence of cytokines, chronic hypoxia
only marginally altered hypoxic cell radioresponse in micropellets.
The specificity of iNOS induction in chronic hypoxia was
confirmed with the iNOS inhibitor aminoguanidine that abrogated
the radiosensitizing effect of cytokines (Figure 4B). 
DISCUSSION 
This study shows that chronic hypoxia in the range of 0.03–1%
oxygen increases the potency of cytokines IL-1b and IFN-g to acti-
vate iNOS in EMT-6 tumour cells. In comparison to aerobic cells,
hypoxic cells revealed substantially up-regulated levels of iNOS
protein when exposed to low concentration of cytokines (0.3–
1 units ml–1). In the absence of cytokines, no iNOS was found in
aerobic cells while hypoxic cells expressed iNOS at a low but
detectable level. Compared to 1% oxygen, the radiobiologically
relevant hypoxia level of 0.03% oxygen further potentiated
cytokine effects as suggested by nitrite accumulation and protein
expression. Activation of iNOS in hypoxic EMT-6 cells was
controlled at the transcriptional level since protein expression
reflected mRNA levels. Transcriptional up-regulation of iNOS in
moderate hypoxia (1% oxygen) was previously shown in human
hepatocellular carcinoma Hep3B cells (Yoshioka et al, 1997) but
was absent in human intestinal adenocarcinoma DLD-1 cells
(Salzman et al, 1996). While synergism of cytokines and hypoxia
in iNOS induction is well established for macrophages (Melillo
et al, 1995) such an interaction may not always be present in
tumour cells that display different profiles of cytokine receptors
and hypoxia-inducible transcription factors. 
Although activation of iNOS in both stromal and tumour cells is
described for many malignancies (Thomsen et al, 1994, 1995;
Ambs et al, 1998; Thomsen and Miles, 1998), the level and role of
NO in tumour physiology are not clear. A growing body of
evidence suggests that NO production in tumour occurs at a low
rate and provides primarily a positive growth signal (Thomsen and
Miles, 1998; Wink et al, 1998; Dachs and Tozer, 2000). To achieve
radiosensitization, much higher NO concentrations may be
required as show our studies with NO donors (Verovski et al,
1996; Janssens et al, 1999) and other reports (Griffin et al, 1996;
Mitchell et al, 1996). However no obvious correlation between
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Figure 3 NO production in EMT-6 cells after a 16 h exposure to IFN-g and
IL-1b in 21% (n n) or 1% ( ) oxygen. The NO signal was registered by a NO-
specific microsensor in concentrated cell suspensions (30 ´ 106 ml–1) 
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Figure 4 Radiosensitivity of EMT-6 cells after a 16 h exposure to IFN-g and
IL-1b in 21% (A) or 1% (B) oxygen. EMT-6 cells, not treated (u u) or treated
with cytokines at 1 (l l) or 3 (l) units ml–1, were isolated and analysed for
hypoxic cell radiosensitivity in micropellets. The iNOS inhibitor
aminoguanidine (1 mM) was added 1 h prior to cell isolation (s). The
survival curve for aerobic cells (u) is plotted for reference Chronic hypoxia and iNOS-mediated radiosensitization 1125
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NO levels and radiosensitization was found and NO produced
intracellularly in the proximity of radiation targets is likely to be
more effective than chemical NO releasers. Indeed, we demon-
strated that iNOS generates a 10-times lower NO output compared
to that of the NO donor PAPA/NO yet resulting in comparable
radiosensitization (Janssens et al, 1998). 
Therefore, we raised the question whether cytokine-induced
iNOS activation in chronic hypoxia results in sufficient NO
production to achieve radiosensitization. Secondly, we asked
whether chronic hypoxia may increase the radiosensitizing
potency of cytokines that would be consistent with up-regulated
profiles of iNOS expression in hypoxia. We have measured NO
output in EMT-6 cells using a NO-specific sensor and found a
remarkable increase in NO signal induced by 1 unit ml–1 cytokines
in hypoxia but not in normoxia. Likewise, selective induction of
iNOS in hypoxia resulted in significant radiosensitization (1.8-
fold) that could be abrogated by the iNOS inhibitor aminoguani-
dine. In contrast, aerobic cytokine treatment was not effective at
1 unit ml–1, and chronic hypoxia alone had little effect on radiosen-
sitivity. Taken together, these data suggest that chronic hypoxia
does up-regulate iNOS expression in tumour cells but that it
sustains rather than triggers iNOS activation. Hence, cytokines
continue to play a crucial role in iNOS activation and iNOS-
mediated radiosensitization. Whether this mechanism is opera-
tional in human tumour cells and which tumours overexpress
iNOS in hypoxia remains to be explored. 
In conclusion, chronic hypoxia up-regulates cytokine-induced
expression of iNOS in EMT-6 tumour cells resulting in appearance
of functionally active enzyme. Therefore hypoxia may potentially
be exploited to increase the radiosensitizing activity of cytokines
through the iNOS pathway. 
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